EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review

Pedro de Pablos-Rodríguez, Aythami de Armas-Castellano, Diego Infante-Ventura, Tasmania Del Pino-Sedeño, Antonio Rueda Domínguez, Pablo B Pedrianes-Martín, Jose A L Calbet, Pedro de Pablos-Velasco iD, María M Trujillo-Martín

Journal of Cachexia, Sarcopenia and Muscle · 2026-06 · 17 (3)

DOI: 10.1002/jcsm.70290 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 05.05.2026. Verfasst von Pedro de Pablos-Rodríguez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Instituto Valenciano de Oncología (IVO), Valencia, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Sarcopenia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia has emerged as a potential prognostic factor in patients with advanced prostate cancer (PCa), requiring interventions for its prevention and treatment.

Objective

We aimed to systematically identify, critically assess and synthesize the available evidence on the effectiveness and safety of interventions for preventing or treating sarcopenia in advanced PCa patients.

Methods

MEDLINE, Embase and Web of Science were searched. Randomized and non‐randomized controlled trials or longitudinal observational studies with a control group focusing on PCa patients aged 60 years and older were considered. Study selection, data extraction and risk‐of‐bias assessment of the included studies were performed in duplicate. When possible, pooled effect estimates were calculated.

Results

Twenty studies ( n = 1275) were included. Resistance training (RT) (MD = 3.22 kg; 95% CI 0.69, 5.75) and the use of antimyostatin peptibody (MD = 2.2 kg; SE 0.8%) demonstrated statistically significant prevention of lean body mass loss in men undergoing androgen deprivation therapy (ADT). Exercise improved leg press (MD = 25.17 kg; 95% CI [8.71, 41.62]), leg extension (MD = 9.63 kg; 95% CI [4.83, 14.42]), seated row (MD = 4.38 kg; 95% CI [1.54, 7.22]) and chest press strength (MD = 1.70 kg; 95% CI [−1.48, 4.88]) and enhanced patients' physical functioning in chair sit‐to‐stand tests (MD = −1.02 kg; 95% CI [−1.70, −0.34]). RT improved health‐related quality of life (HRQoL) in both general and specific domains and also reduced somatization (MD = −0.69 kg; 95% CI [−1.32, −0.07]) and psychological distress (MD = −1.63 kg; 95% CI [−3.10, −0.15]).

Conclusions

The findings highlight the potential benefits of RT and selected pharmacological interventions on muscle‐related and functional outcomes. However, the significant heterogeneity and lack of comprehensive outcome reporting underscore the need for more standardized and long‐term research through larger, well‐designed randomized controlled trials with standardized measurement methods to draw conclusive evidence and enhance the reliability and applicability of findings in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsSarcopeniaHumansMaleTreatment OutcomeQuality of Life

Stichwörter der Autor:innen

meta‐analysismuscleprostatic neoplasmquality of lifesarcopeniasystematic review

Autor:innen und Institutionen

  • Department of Urology, Instituto Valenciano de Oncología (IVO), Valencia, Spain.
  • Canry Islands Health Research Institute Foundationa (FIISC), Las Palms de Gran Canaria, Spain.
  • Canary Islands Health Research Institute Foundation (FIISC), El Rosario, Santa Cruz de Tenerife, Spain.
  • Evaluation Unit of the Canary Islands Health Service (SESCS), El Rosario, Santa Cruz de Tenerife, Spain.
  • Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Madrid, Spain.
  • Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.

ORCID-Profile: Pedro de Pablos-Velasco

Zitieren

APA

de Pablos-Rodríguez, P., de Armas-Castellano, A., Infante-Ventura, D., Del Pino-Sedeño, T., Domínguez, A. R., Pedrianes-Martín, P. B., Calbet, J. A. L., de Pablos-Velasco, P., & Trujillo-Martín, M. M. (2026). Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review. Journal of Cachexia, Sarcopenia and Muscle, 17(3). https://doi.org/10.1002/jcsm.70290

Vancouver

de Pablos-Rodríguez P, de Armas-Castellano A, Infante-Ventura D, Del Pino-Sedeño T, Domínguez AR, Pedrianes-Martín PB, et al. Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(3). doi:10.1002/jcsm.70290

BibTeX
@article{dePablosRodrguez2026,
  author = {de Pablos-Rodríguez, Pedro and de Armas-Castellano, Aythami and Infante-Ventura, Diego and Del Pino-Sedeño, Tasmania and Domínguez, Antonio Rueda and Pedrianes-Martín, Pablo B and Calbet, Jose A L and de Pablos-Velasco, Pedro and Trujillo-Martín, María M},
  title = {Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1002/jcsm.70290}
}
Kostenlos starten →